How big is the brachytherapy market today, and what are its future growth expectations?
The brachytherapy market size has grown strongly in recent years. It will grow from $0.93 billion in 2024 to $1.01 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing cancer incidence, raising awareness and early detection efforts, growing awareness of brachytherapy’s effectiveness and reduced side effects, favorable reimbursement policies in various regions, approval and standardization of brachytherapy procedures and devices.
The brachytherapy market size is expected to see strong growth in the next few years. It will grow to $1.37 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to tailoring treatments based on genetic and molecular profiles, increasing demand due to higher cancer incidence in elderly populations, expansion of healthcare facilities supporting brachytherapy, higher investments in cancer treatment, increasing preference for less invasive therapies. Major trends in the forecast period include innovation in brachytherapy techniques and equipment, personalized medicine, integration of advanced imaging technologies such as MRI and PET-CT for real-time guidance during brachytherapy procedures, growing preference for outpatient brachytherapy procedures, and advanced brachytherapy technology.
Get Your Free Sample of The Global Brachytherapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17104&type=smp
What have been the primary factors driving the brachytherapy market’s growth?
The increasing cancer burden is expected to propel the growth of the brachytherapy market going forward. The cancer burden is rising due to aging populations, lifestyle changes, and increased exposure to risk factors such as tobacco, poor diet, and environmental pollutants. Brachytherapy is used to manage the cancer burden by offering a targeted and effective treatment option that can be tailored to various types of cancer, providing localized therapy while minimizing overall treatment time and side effects. For instance, in January 2022, according to the American Cancer Society, a US-based cancer awareness non-profit organization, in the US, an estimated 1.9 million new cancer cases and 609,360 cancer-related deaths are expected, reaching up to approximately 1,670 deaths daily. Globally, the most prevalent cancers include lung, prostate, colorectal, and breast cancers, constituting 43% of all newly diagnosed cases. Therefore, the increasing cancer burden will drive the brachytherapy market.
What are the key segments within the brachytherapy market?
The brachytherapy market covered in this report is segmented –
1) By Product Type: Seeds, Applicators And Afterloaders, Electronic Brachytherapy
2) By Dosage Type: High-Dose Rate (HDR) Brachytherapy, Low-Dose Rate (LDR) Brachytherapy
3) By Application: Prostate Cancer, Gynecological Cancer, Breast Cancer, Other Applications
4) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Seeds: Iodine-125 Seeds, Palladium-103 Seeds, Cesium-131 Seeds, Other Radioactive Seeds
2) By Applicators And Afterloaders: Prostate Applicators, Vaginal Applicators, Interstitial Applicators, Skin Applicators, Afterloaders
3) By Electronic Brachytherapy: Electronic Brachytherapy Units, Electronic Brachytherapy Sources
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/brachytherapy-global-market-report
Which key players are shaping the brachytherapy market?
Major companies operating in the brachytherapy market are Siemens Healthineers, Becton Dickinson and Company, Boston Scientific Corporation, Hologic Inc., Varian Medical Systems Inc., Carl Zeiss AG, Elekta, Argon Medical Devices Inc., Sirtex Medical Limited, Theragenics Corporation, RaySearch Laboratories, Nanobiotix SA, CIVCO Medical Solutions, Eckert Ziegler Bebig GmbH, iCAD Inc., IsoAid, C4 Imaging LLC, Mick Radio-Nuclear Instruments Inc., Huiheng Medical Inc., Best Medical International Inc., Cianna Medical Inc.
How will emerging trends drive the brachytherapy market throughout the forecast period?
Major companies operating in the brachytherapy market are focused on developing innovative technological solutions, such as standard afterloader technology, to enhance treatment precision and efficacy. Standard afterloader technology in brachytherapy refers to automated devices that deliver radioactive sources to tumor sites, ensuring precise radiation dose administration. For instance, in April 2024, Varian Medical Systems, a US-based medical device manufacturing company, partnered with Maastro, a US-based radiotherapy clinic, to launch an innovative brachytherapy applicator designed for accurate delivery of HDR brachytherapy in the treatment of rectal cancer. The new partially 3D-printed applicator was co-developed by Maastro radiation oncologists and physicists together with Varian experts to provide radiotherapists with improved treatment options for rectal cancer patients. The applicator is designed to increase contact with the tumor and provide a uniform dose distribution, with a dose range similar to that of contact X-ray brachytherapy (CXB).
How do regional factors impact the brachytherapy market, and which region is the largest contributor?
North America was the largest region in the brachytherapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brachytherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Brachytherapy Market Report 2025 Offer?
The brachytherapy market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Brachytherapy is a form of radiotherapy where radioactive sources are placed directly into or near the tumor. This allows for the targeted delivery of radiation to cancerous tissues while minimizing exposure to surrounding healthy tissues. It’s commonly used to treat prostate, cervical, and skin cancers, among others, offering a localized and effective treatment option.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17104
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
